Company Overview of Icon Group
Icon Group engages in movie production, sales, marketing, and distribution. The company is based in the Los Angeles, California.
Los Angeles, CA
Key Executives for Icon Group
Compensation as of Fiscal Year 2016.
Icon Group Key Developments
Archer Considers Buying Icon Group
Mar 16 17
Archer Capital is considering buying Icon Group as Chinese suitors are joining the conga line of parties in the pursuit of hotly sought-after company. Quadrant Private Equity Pty Limited is working with Credit Suisse Group AG (SWX:CSGN) to sell the business which will understood to be fetched $1.4 billion. Other groups around the hoop are The Carlyle Group LP (NasdaqGS:CG), Healthe Care Australia Pty Ltd., EBOS Group Limited (NZSE:EBO), Sigma Pharmaceuticals Limited (ASX:SIP) and TPG Capital, L.P. Bain Capital, LP is now known to be sitting out the sale process, with potential bidders trawling through the details of the operation within its information memorandum.
Banks Eye Buyer Group For Icon
Feb 28 17
Macquarie Capital and UBS are understood to be moving to drum up a buyers' consortium to advise for the sales process of Quadrant Private Equity Pty Limited's Icon Group. EBOS Group Limited (NZSE:EBO) and Healthscope Limited (ASX:HSO) and Definity Health Corporation are among the parties being urged to join forces to bid for the $1.4 billion Australian cancer care provider. Others also potentially being courted are Sigma Pharmaceuticals Limited (ASX:SIP) and Australian Pharmaceutical Industries Limited (ASX:API).
Quadrant Seeks To Sell Icon
Dec 9 16
Icon Group is believed to be launching a non-deal roadshow through Asia in January 2017, as trade buyers continue to seek out the $1.5 billion-plus healthcare business. So far, Icon, which is owned by Quadrant Private Equity Pty Limited, is understood to have attracted interest from private equity firms including TPG Capital, L.P. and The Carlyle Group LP (NasdaqGS:CG). Bain Capital Credit, LP is also likely to be an eager buyer, along with parties from Asia. Credit Suisse has been hired as an adviser to divest the business and it is expected that another bank will join the Swiss financial group - potentially the rival from its homeland, UBS, after the pair successfully sold GenesisCare for Kohlberg Kravis Roberts for a bullish $1.7 billion. Quadrant is thought to be keeping its options open for the divestment of Icon, which may also be sold via an initial public offering.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries